OncoCyte Corp

-0.14 (-3.14%)
Officer Changes, Earnings Announcements

Oncocyte Corp Terminated Chief Operating Officer's Employment as Part Of Cost Savings Plan

Published: 09/28/2020 17:03 GMT
OncoCyte Corp (OCX) - Oncocyte Corp - on September 28, Full-time Employment of Albert Parker, Chief Operating Officer Was Terminated As Part of Cost Savings Plan.
Oncocyte Corp - Parker Accepted Offer to Continue to Serve Temporarily in Current Position on Part-time at Will Basis.
Oncocyte Corp - Part-time Employment Will Terminate on December 18, 2020.
Revenue is expected to be $0.84 Million
Adjusted EPS is expected to be -$0.10

Next Quarter Revenue Guidance is expected to be $1.33 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.